Cardiology

Richard Clinton Becker, MD

Adjunct Professor in the Department of Medicine
Member in the Duke Clinical Research Institute
Campus mail 231 Albert Sabin Way, Cincinnati, OH 45267
Phone (513) 558-4332
Email address richard.becker@duke.edu

Education and Training

  • Chief Medical Resident, Medicine, Case Western Reserve University, 1995 - 1996
  • Fellow in Cardiology, Medicine, U Mass Memorial Medical Center, 1986 - 1989
  • Medical Resident, Mecicine, Case Western Reserve University, 1982 - 1985
  • M.D., University of Cincinnati, 1982

Grants

Publications

Cox, J., and S. Schwarcz. “Foreword.” Law & Contemporary Problems 78, no. 3 (2015): i–v.

Scholars@Duke

Vavalle, J. P., C. P. Rusconi, S. Zelenkofske, W. A. Wargin, T. L. Ortel, J. H. Alexander, T. J. Povsic, and R. C. Becker. “The effect of the REG2 Anticoagulation System on thrombin generation kinetics: a pharmacodynamic and pharmacokinetic first-in-human study..” J Thromb Thrombolysis 38, no. 3 (October 2014): 275–84. https://doi.org/10.1007/s11239-014-1081-6.

PMID
24880800
Full Text

Welsby, Ian J., Barbara Phillips-Bute, Joseph P. Mathew, Mark F. Newman, Richard Becker, Sunil Rao, Carmelo A. Milano, and Mark Stafford-Smith. “ABO blood group influences transfusion and survival after cardiac surgery..” J Thromb Thrombolysis 38, no. 3 (October 2014): 402–8. https://doi.org/10.1007/s11239-013-1045-2.

PMID
24935230
Full Text

Piccini, Jonathan P., Jyotsna Garg, Manesh R. Patel, Yuliya Lokhnygina, Shaun G. Goodman, Richard C. Becker, Scott D. Berkowitz, et al. “Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial..” Eur Heart J 35, no. 28 (July 21, 2014): 1873–80. https://doi.org/10.1093/eurheartj/ehu083.

PMID
24658769
Full Text

Halperin, Jonathan L., Graeme J. Hankey, Daniel M. Wojdyla, Jonathan P. Piccini, Yuliya Lokhnygina, Manesh R. Patel, Günter Breithardt, et al. “Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)..” Circulation 130, no. 2 (July 8, 2014): 138–46. https://doi.org/10.1161/CIRCULATIONAHA.113.005008.

PMID
24895454
Full Text

Akerblom, Axel, Niclas Eriksson, Lars Wallentin, Agneta Siegbahn, Bryan J. Barratt, Richard C. Becker, Andrzej Budaj, et al. “Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study..” Am Heart J 168, no. 1 (July 2014): 96-102.e2. https://doi.org/10.1016/j.ahj.2014.03.010.

PMID
24952865
Full Text

Husted, Steen, Stefan K. James, Richard G. Bach, Richard C. Becker, Andrzej Budaj, Magda Heras, Anders Himmelmann, et al. “The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial..” Eur Heart J 35, no. 23 (June 14, 2014): 1541–50. https://doi.org/10.1093/eurheartj/ehu075.

PMID
24682844
Full Text

Wong, Ka Sing Lawrence, Dai Yi Hu, Abraham Oomman, Ru-San Tan, Manesh R. Patel, Daniel E. Singer, Günter Breithardt, et al. “Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial..” Stroke 45, no. 6 (June 2014): 1739–47. https://doi.org/10.1161/STROKEAHA.113.002968.

PMID
24763930
Full Text

Steinberg, Benjamin A., Anne S. Hellkamp, Yuliya Lokhnygina, Jonathan L. Halperin, Günter Breithardt, Rod Passman, Graeme J. Hankey, et al. “Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial..” Heart Rhythm 11, no. 6 (June 2014): 925–32. https://doi.org/10.1016/j.hrthm.2014.03.006.

PMID
24833235
Full Text

Pages